 "SPARC Q1 net profit at Rs 9.51 cr")
Sun Pharma Advanced Research Company (SPARC) today reported a net profit of Rs 9.51 crore for the quarter ended June 30, 2013.
The company had posted a net loss of 18.32 crore for the corresponding quarter previous fiscal, SPARC said in a statement.
Total income of the company rose to Rs 35.67 crore for the quarter under consideration from Rs 6.38 crore from the same period year ago.
Also Read
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
Shares of Sun Pharma Advanced Research Company were today trading at Rs 128.30 apiece in the afternoon trade on BSE, down 5% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%